Twist Bioscience
TWST
218 hedge funds and large institutions have $2.5B invested in Twist Bioscience in 2023 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 55 increasing their positions, 75 reducing their positions, and 20 closing their positions.
130% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 20
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
86% more capital invested
Capital invested by funds: $1.34B → $2.5B (+$1.16B)
12% more funds holding
Funds holding: 194 → 218 (+24)
2.9% more ownership
Funds ownership: 114.81% → 117.71% (+2.9%)
21% less call options, than puts
Call options by funds: $11.8M | Put options by funds: $15M
27% less repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 75
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$45.4M |
| 2 |
Morgan Stanley
New York
|
+$26.9M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$20M |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$9.88M |
| 5 |
Man Group
London,
United Kingdom
|
+$6.71M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$46.1M |
| 2 |
State Street
Boston,
Massachusetts
|
-$14.7M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$12.3M |
| 4 |
JP Morgan Chase
New York
|
-$10.4M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$8.21M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
JF
226
Jump Financial
Chicago,
Illinois
| – | -$323K | -15,959 | Closed |
|
227
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
| – | -$279K | -13,778 | Closed |
|
228
Point72 Asset Management
Stamford,
Connecticut
| – | -$180K | -7,774 | Closed |
|
|
PMEF
229
Point72 Middle East FZE
Dubai,
United Arab Emirates
| – | -$112K | -5,541 | Closed |
|
230
Allspring Global Investments
Charlotte,
North Carolina
| – | -$70K | -3,453 | Closed |
|
|
CG
231
Cutler Group
San Francisco,
California
| – | -$6K | -300 | Closed |
|
|
CSPIA
232
Cary Street Partners Investment Advisory
Richmond,
Virginia
| – | -$3.12K | -154 | Closed |
|
233
Amundi
Paris,
France
| – | -$1.89K | -111 | Closed |
|
|
TCM
234
Tradewinds Capital Management
Bellingham,
Washington
| – | -$2.03K | -100 | Closed |
|
235
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | -$1.5K | -74 | Closed |
|
|
GBT
236
Grove Bank & Trust
Miami,
Florida
| – | -$1.16K | -57 | Closed |
|
|
MPWT
237
MassMutual Private Wealth & Trust
Windsor,
Connecticut
| – | -$344 | -17 | Closed |
|
TWST Hedge Fund Activity: Q4 2023 in Review
218 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q4 2023, worth a combined $2.5B — up 86% from $1.34B a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new TWST positions and 20 closed out — a net gain of 26 holders — while 55 added to existing stakes and 75 trimmed.
The largest buyer was Artisan Partners, adding an estimated $45.4M. The largest seller was Millennium Management, cutting an estimated $46.1M.
- 218 institutional investors held Twist Bioscience (TWST) as of Q4 2023, up from 194 in Q3 2023.
- Funds reported $2.5B of Twist Bioscience stock for Q4 2023, up 86% quarter-over-quarter.
- 46 funds opened new Twist Bioscience positions in Q4 2023 and 20 closed out, a net change of +26 holders.
- The largest Twist Bioscience buyer in Q4 2023 was Artisan Partners, an estimated $45.4M added.
- The largest Twist Bioscience seller in Q4 2023 was Millennium Management, an estimated $46.1M sold.
Based on aggregated 13F filings for Q4 2023.